CSBR Stock Summary and Trading Ideas (Champions Oncology | NASDAQ:CSBR)

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.

Champions Oncology trades on the NASDAQ stock market under the symbol CSBR.

As of August 14, 2026, CSBR stock price declined to $5.05 with 3,132 million shares trading.

CSBR has a market cap of $70.13 million. This is considered a Micro Cap stock.

Last quarter Champions Oncology reported $14 million in Revenue and $.01 earnings per share. This beat revenue expectation by $949,000 and exceeded earnings estimates by $.06.

In the last 3 years, CSBR traded as high as $11.99 and as low as $3.60.

The top ETF exchange traded funds that CSBR belongs to (by Net Assets): VTI, VXF, IWC.

CSBR has underperformed the market in the last year with a price return of -26.2% while the SPY ETF gained +21.5%. CSBR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -16.1% and -4.0%, respectively, while the SPY returned +4.8% and +4.7%, respectively.

CSBR support price is $4.81 and resistance is $5.35 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CSBR shares will trade within this expected range on the day.